Advanced in Acne

Dr. Jonathan I. Silverberg

Dermatology
Medical Faculty Associates, Inc
2150 Pennsylvania Ave Nw, 
Washington, DC 
Accepting New Patients
16 Years of Experience
Advanced in Acne
Medical Faculty Associates, Inc
2150 Pennsylvania Ave Nw, 
Washington, DC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jonathan Silverberg is a Dermatologist in Washington, Washington, D.c.. Dr. Silverberg has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Acne. His top areas of expertise are Atopic Dermatitis, Stasis Dermatitis and Ulcers, Contact Dermatitis, and Vitiligo. Dr. Silverberg is currently accepting new patients.

His clinical research consists of co-authoring 749 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Acne.

Graduate Year
2009
Specialties
Dermatology
Licenses
Dermatology in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

MEDICAL FACULTY ASSOCIATES, INC
2150 Pennsylvania Ave Nw, Washington, DC 20037

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: August 03, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 3 Less Clinical Trials

748 Total Publications

Nearly Half of American Children with Atopic Dermatitis Experience Significant Quality of Life Impairment, Often Underestimated by Parents.
Nearly Half of American Children with Atopic Dermatitis Experience Significant Quality of Life Impairment, Often Underestimated by Parents.
Journal: The British journal of dermatology
Published: September 03, 2025
Similar Doctors
Elite in Acne
Dr. Valerie D. Callender
Dermatology
Elite in Acne
Dr. Valerie D. Callender
Dermatology
12200 Annapolis Rd, 
Glenn Dale, MD 
 (14.2 miles away)
301-249-0970
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Valerie Callender is a Dermatologist in Glenn Dale, Maryland. Dr. Callender is rated as an Elite provider by MediFind in the treatment of Acne. Her top areas of expertise are Acne, Melasma, Autosomal Recessive Hypotrichosis, and Contact Dermatitis. Dr. Callender is currently accepting new patients.

Elite in Acne
Dr. Lawrence J. Green
Dermatology
Elite in Acne
Dr. Lawrence J. Green
Dermatology

Privia Medical Group, LLC

9470 Annapolis Rd, Suite 309, 
Lanham, MD 
 (12.0 miles away)
202-832-1800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lawrence Green is a Dermatologist in Lanham, Maryland. Dr. Green is rated as a Distinguished provider by MediFind in the treatment of Acne. His top areas of expertise are Acne, Plaque Psoriasis, Psoriasis, and Rosacea. Dr. Green is currently accepting new patients.

Distinguished in Acne
Dr. Sewon P. Kang
Dermatology
Distinguished in Acne
Dr. Sewon P. Kang
Dermatology

Johns Hopkins University

600 N Wolf St, 
Baltimore, MD 
 (36.7 miles away)
410-955-5000
Languages Spoken:
English, Korean
See accepted insurances
Accepting New Patients

Sewon Kang is a Dermatologist in Baltimore, Maryland. Dr. Kang is rated as a Distinguished provider by MediFind in the treatment of Acne. His top areas of expertise are Acne, Melanoma, Prurigo Nodularis, and Rosacea. Dr. Kang is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Silverberg's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 18 Advanced Conditions
View All 20 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile